William E. Rote, SVP, R&d: Travere Therapeutics TVTX Sell · Filed 24/01/25

Trade details

Type: Insider sale
Amount: $18,475.52
Shares · price: 2,062 sh · $8.96 a share
Held after: 60,484 sh
Stock: Travere Therapeutics TVTX
Person: William E. RoteSVP, R&d
Trade date: 24/01/23
Filed: 24/01/25
Days to filing: 2 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/24~24/02/22

William E. Rote's recent trades

William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$7.1M
112,850 sh
$7.1M
Filed 09/16
Traded 09/16
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.3M
96,198 sh
$6.3M
Filed 09/15
Traded 09/15
William E. RoteChief Research Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$355.7K
9,100 sh
$355.7K
Filed 04/23
Traded 04/22